tiprankstipranks
Blueberries Medical Corp (BBRRF)
OTHER OTC:BBRRF

Blueberries Medical (BBRRF) Stock Price & Analysis

50 Followers

BBRRF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.03
Previous Close$0.01
Volume57.00K
Average Volume (3M)54.63K
Market Cap
$4.00M
Enterprise Value$5.24M
Total Cash (Recent Filing)C$594.26K
Total Debt (Recent Filing)C$1.60M
Price to Earnings (P/E)-3.3
Beta0.85
May 01, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding218,309,152
10 Day Avg. Volume15,946
30 Day Avg. Volume54,630
Standard Deviation0.28
R-Squared0.06
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)11.17
Price to Sales (P/S)10.31
Price to Cash Flow (P/CF)-8.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

BBRRF FAQ

What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
    What is Blueberries Medical Corp’s market cap?
    Currently, no data Available
    When is Blueberries Medical Corp’s upcoming earnings report date?
    Blueberries Medical Corp’s upcoming earnings report date is May 01, 2024 which is in 6 days.
      How were Blueberries Medical Corp’s earnings last quarter?
      Blueberries Medical Corp released its earnings results on Nov 24, 2023. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
        Is Blueberries Medical Corp overvalued?
        According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Blueberries Medical Corp pay dividends?
          Blueberries Medical Corp does not currently pay dividends.
          What is Blueberries Medical Corp’s EPS estimate?
          Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Blueberries Medical Corp have?
          Blueberries Medical Corp has 218,309,160 shares outstanding.
            What happened to Blueberries Medical Corp’s price movement after its last earnings report?
            Blueberries Medical Corp reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Blueberries Medical Corp?
              Currently, no hedge funds are holding shares in BBRRF
              ---

              Blueberries Medical Stock Smart Score

              Company Description

              Blueberries Medical Corp

              Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogota Savannah of central Colombia and operations currently being established in Argentina. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries' combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Auxly Cannabis Group
              Cresco Labs
              Trulieve Cannabis
              Cronos Group
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis